Fungal Testing Kits Market in Europe is expected to register growth of 10.3% through 2030

The global Fungal Testing Kits Market is anticipated to increase significantly between 2022 and 2030, with a 10.4% CAGR, reaching an estimated market value of about US$ 1.55 Billion in 2022. According to Future Market Insights’ predictions, diagnostic laboratories will retain a sizeable market share of more than 51.8% in 2021.

The growing prevalence of superficial and systemic fungal infections has posed a significant challenge to healthcare providers across the world. The increasing prevalence of fungal infections of the skin, vagina, and blood has prompted vendors to concentrate on developing swift and advanced molecular diagnostics in recent years.

Techniques such as real-time testing have led to the massive proliferation of the fungal testing kits market, with technologies such as loop mediated isothermal amplification coming to the forefront. Molecular diagnostic-based tests have immensely assisted in administering timely treatment to severely infected patients, thereby reducing fatalities.

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12418

Fungal Testing Kits Market- Key Takeaways

  • Widening expenditure on healthcare infrastructure to uplift demand across Asia-Pacific
  • Molecular detection tests to tower over others, reaching US$ 1.6 Bn by 2030
  • Skin samples are anticipated to capture the lion’s share, accounting for over 40% of the market
  • Medical diagnosis to remain core application area, generating an attractiveness index of 2.8

“Sustained focus on incorporating technological advancements to improve diagnostic outcomes remains the core objective of fungal testing kits manufacturers, enabling them to widen their revenue pools,” infers the FMI analyst.

Competitive Intelligence

Prominent players include:

  • Biomed Diagnostics, Inc.
  • Bioquochem
  • C.P.M. Diagnostic Research SAS
  • ELITech Group
  • ADT Biotech
  • Cole-Parmer India Pvt. Ltd.
  • PerkinElmer
  • GenMark Diagnostics, Inc.
  • Norgen Biotek
  • PCRmax
  • Merck KGaA
  • Thermofisher Scientfic

In May 2019, Thermo Fisher Scientific announced the acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies for US$ 1.7 billion. The acquisition has helped the former enhance its laboratory products and services portfolio.

Ask the Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-12418

In 2018, PerkinElmer Inc. announced development of the Quasar C-18 used to compare Clotrimazole HPLC analysis. In February 2020, GenMark Diagnostics Inc. published a pipeline study detailing the effectiveness of a PCR-based digital microfluidics and electrochemical detection system for rapid identification of 15 fungal pathogens.

Yeast testing kits are diagnostic tools designed to identify the presence of fungi in various types of samples, including environmental samples, food, and clinical specimens. These kits typically use different methods to detect fungal organisms, such as DNA-based techniques, immunoassays, and culture-based methods.

More Insights on the Fungal Testing Kits Market

Future market Insights offer a unique perspective and actionable insights on fungal testing kits market in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on test type (Molecular test, chromogenic test and others), by sample type (Skin, urine , vaginal secretions, blood, cerebral and others), by application (Research, Susceptibility Testing, Medical Diagnosis and others) by End user (Diagnostic Laboratory, Hospitals, Pharmaceutical Companies, Research and Academic Institutes) in seven key regions.

Use promo code ->> FMITODAY to get a flat 20% discount

Key Market Segments Covered In Fungal Testing Kits Industry Research

By Test Type:

  • Molecular Test
  • Chromogenic Test
  • Others

By Sample Type:

  • Skin
  • Urine
  • Vaginal secretions
  • Blood
  • Cerebral
  • Others

By Application:

  • Research
  • Susceptibility Testing
  • Medical Diagnosis
  • Others

By End User:

  • Diagnostic Laboratory
  • Hospitals
  • Pharmaceutical Companies
  • Research and Academic Institutes

Explore FMI’s Extensive ongoing Coverage in Healthcare Domain:

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these